Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
NHS
19,100 stories
FDA
4,555 stories
Salon
1,703 stories
NHS England
1,181 stories
NICE
1,024 stories
Eli Lilly
673 stories
UCL
331 stories
CMS
312 stories
Lilly
303 stories
Biogen
275 stories
KFF
247 stories
Alzheimer Society
209 stories
the Food and Drug Administration
118 stories
Eisai
99 stories
Alzheimer Research UK
97 stories
Biogen Inc
82 stories
Eli Lilly and Company
48 stories
the Alzheimer Association
31 stories
JAMA
30 stories
Leqembi
24 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics